Hagens Berman has opened a legal investigation into CVRx following a U.S. Department of Justice Civil Investigative Demand concerning possible false claims and kickbacks related to its heart failure device, Barostim. The company also cut its 2026 revenue guidance sharply, revealed sales force problems, and saw a major Medicare Advantage approval drop. After these disclosures, CVRx's stock fell 59%, and the Chief Revenue Officer was abruptly fired. The investigation will examine if CVRx misled investors about its sales and reimbursement status and the link between the DOJ probe and the CRO's termination.
Designer Brands Inc. reported Q2 earnings of $0.34 per share, beating estimates by 36%, but revenue fell 1.2% year-over-year to $730.63 million, missing expectations. The company improved profitability with an expanded adjusted gross margin of 47.9%,...
The Lovesac Company reported a better-than-expected Q2 earnings per share (EPS) of -$0.35, beating estimates by over 10% and improving from a -$0.45 loss a year ago. Despite this EPS beat, the company's revenue of $161.25 million narrowly missed anal...
Copart, Inc. is set to report its Q3 earnings with analysts expecting an EPS of $0.38, down from $0.41 last year, while revenue is projected to increase slightly to $1.14 billion from $1.13 billion. The company faces headwinds from a weak US market a...
Agree Realty Director Rakolta has purchased 20,136 shares of the company, investing approximately $1.5 million. This insider buying could signal confidence in the company's future prospects. Investors may view this as a positive sign, potentially imp...
MasterCraft Boat Holdings reported Q4 earnings of $0.67 per share, surpassing analyst estimates of $0.61 and up from $0.40 a year ago. Revenue reached $129.94 million, well above the expected $93.05 million. The company maintains a strong current rat...
